Alex

Alex is a writer and digital content enthusiast who enjoys covering technology, current trends, useful tips, and topics that matter to everyday readers. With a focus on clear, informative, and easy-to-understand content, Alex aims to provide readers with practical insights and interesting perspectives across a wide range of subjects.
Image_20230327191436-1

L’Officiel Inc. SAS Granted Permits by the Ministry of Home Affairs of Malaysia to Publish Locally and Achieved Another Milestone Under the Direct Owner’s Model

Alex March 27, 2023

NEW YORK & HONG KONG & SINGAPORE--(BUSINESS WIRE)--L’Officiel Inc. SAS (“L’Officiel”), a subsidiary of AMTD IDEA Group (NYSE: AMTD; SGX:...

Read MoreRead more about L’Officiel Inc. SAS Granted Permits by the Ministry of Home Affairs of Malaysia to Publish Locally and Achieved Another Milestone Under the Direct Owner’s Model
Image_20230327191436

L’Officiel Inc. SAS Granted Permits by the Ministry of Home Affairs of Malaysia to Publish Locally and Achieved Another Milestone Under the Direct Owner’s Model

Alex March 27, 2023

NEW YORK & HONG KONG & SINGAPORE--(BUSINESS WIRE)--L’Officiel Inc. SAS (“L’Officiel”), a subsidiary of AMTD IDEA Group (NYSE: AMTD; SGX:...

Read MoreRead more about L’Officiel Inc. SAS Granted Permits by the Ministry of Home Affairs of Malaysia to Publish Locally and Achieved Another Milestone Under the Direct Owner’s Model
LOGO-58

OliX Pharmaceuticals Doses First Patient in Clinical Trial for RNAi Therapeutic OLX10212 for Dry and Wet Age-related Macular Degeneration

Alex March 27, 2023

SUWON, South Korea--(BUSINESS WIRE)--#AMD--OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, today announced that the first patient...

Read MoreRead more about OliX Pharmaceuticals Doses First Patient in Clinical Trial for RNAi Therapeutic OLX10212 for Dry and Wet Age-related Macular Degeneration
LOGO-57

OliX Pharmaceuticals Doses First Patient in Clinical Trial for RNAi Therapeutic OLX10212 for Dry and Wet Age-related Macular Degeneration

Alex March 27, 2023

SUWON, South Korea--(BUSINESS WIRE)--#AMD--OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, today announced that the first patient...

Read MoreRead more about OliX Pharmaceuticals Doses First Patient in Clinical Trial for RNAi Therapeutic OLX10212 for Dry and Wet Age-related Macular Degeneration
logo-FN-purple-red

FiscalNote Announces Major New Customer Agreements with International Governments, Embassies, Agencies, Parliaments, and Ministries Across the Global Public Sector

Alex March 27, 2023

Governments Increasingly Rely on FiscalNote’s Geopolitical, Policy, and Political Intelligence - Powered by AI - For Legislative Tracking, Issue Monitoring,...

Read MoreRead more about FiscalNote Announces Major New Customer Agreements with International Governments, Embassies, Agencies, Parliaments, and Ministries Across the Global Public Sector

You may have missed

gta-6-pre-loads-begin-nov-10-with-212gb-install-as-ai-concerns-shift-pc-timeline-1794233909

GTA 6 Pre-Loads Begin Nov 10 With 212GB Install as AI Concerns Shift PC Timeline

Ananya Suresh November 9, 2026
behind-the-1-crore-bhagyathara-win-how-keralas-daily-lottery-engine-operates-1794232136

Behind the ₹1 Crore Bhagyathara Win: How Kerala’s Daily Lottery Engine Operates

Arjun Nair November 9, 2026
zelda-ocarina-of-time-remake-tops-charts-on-switch-2-as-data-mine-confirms-dlc-1794230343

Zelda Ocarina of Time Remake Tops Charts on Switch 2 as Data Mine Confirms DLC

Ananya Suresh November 9, 2026
alex-michelsen-falls-to-alcaraz-in-paris-heads-to-stockholm-with-ranking-points-in-sight-1794228514

Alex Michelsen falls to Alcaraz in Paris, heads to Stockholm with Ranking points in sight

Rohan Menon November 9, 2026
why-the-twelfth-episode-drives-the-climax-in-global-tv-and-anime-1794224899

Why the Twelfth Episode Drives the Climax in Global TV and Anime

Vivek Raj November 9, 2026